Topic: Diabetes.
Destination: JDRF aims to catalyze and support innovative studies for the selective delivery of therapeutics (bioactive molecules) to human beta cells, or other major pancreatic cell types, to promote survival and restore functional beta-cell mass in type 1 diabetes (T1D).
Budget: $900,000.
Duration: 3 years.
Omple el següent formulari per rebre més informació:
